Hiba Moubayed: Influence Statistics

Hiba Moubayed

Hiba Moubayed

Pharmaceutical Care Services, Division of Clinical Pharmacy, King Abdulaziz Medical City, Riyadh, Saudi Arabia | School of Pharmacy and Chemistry, Kingston University, Penrhyn ...

Hiba Moubayed: Expert Impact

Concepts for which Hiba Moubayed has direct influence: Inborn errors , Patients bisphosphonates , Osteonecrosis jaw , Metabolism iem , Jaw onj , Inborn errors metabolism , Treatment inborn errors .

Hiba Moubayed: KOL impact

Concepts related to the work of other authors for which for which Hiba Moubayed has influence: Inborn errors , Mitochondrial diseases , Bone metastases , Neurometabolic disorders , Urological cancers , Glycine encephalopathy , Osteonecrosis jaw .

KOL Resume for Hiba Moubayed

Year
2013

Pharmaceutical Care Services, Division of Clinical Pharmacy, King Abdulaziz Medical City, Riyadh, Saudi Arabia

2009

School of Pharmacy and Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames KT1 2EE, UK

Prominent publications by Hiba Moubayed

KOL-Index: 5921 . PURPOSE: The risk of osteonecrosis of the jaw (ONJ) associated with bisphosphonate use in patients with cancer is reviewed. SUMMARY: ONJ is a relatively new complication of supportive care in cancer. Bisphosphonate-associated ONJ can be generally defined as necrotic bone exposure to the oral cavity and inflammatory reactions of the surrounding soft tissue in patients receiving ...
Known for Patients Bisphosphonates | Osteonecrosis Jaw | Density Conservation | Diphosphonates Humans
KOL-Index: 3233 . BACKGROUND: The treatment of inborn errors of metabolism (IEM) has seen significant advances over the last decade. Many medicines have been developed and the survival rates of some patients with IEM have improved. Dosages of drugs used for the treatment of various IEM can be obtained from a range of sources but tend to vary among these sources. Moreover, the published dosages are not ...
Known for Inborn Errors | Metabolism Iem | Medicine Humans
KOL-Index: 188 . PURPOSE: With the emerging new warnings surrounding the use of erythropoiesis-stimulating agents (ESAs), the pharmacist's role as health educator and risk communicator expands further to include patient scrutiny to check for eligibility and patient monitoring to check for response or toxicity. This review explores the benefits and risks linked to ESAs use, and the proposed role. SUMMARY: ...
Known for Professional Role

Key People For Inborn Errors

Top KOLs in the world
#1
Georg Friedrich Hoffmann'
newborn screening inborn errors glutaric aciduria type
#2
Jean‐Marie Saudubray
inborn errors peroxisomal disorders prenatal diagnosis
#3
Marinus Duran
inborn errors fatty acids phytanic acid
#4
Bridget M Wilcken
newborn screening cystic fibrosis inborn errors
#5
James Vivian Leonard
inborn errors glycogen storage disease type
#6
Ronald J A Wanders
peroxisomal disorders phytanic acid zellweger syndrome

Pharmaceutical Care Services, Division of Clinical Pharmacy, King Abdulaziz Medical City, Riyadh, Saudi Arabia | School of Pharmacy and Chemistry, Kingston University, Penrhyn Road, Kingston upon Thames KT1 2EE, UK | Hiba Moubayed, Pharm.D., is Resea